[Episodes of clinical manifestations referable to probable involvement of the immune system in 2 sisters with myasthenia gravis].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000549:Ambenonium Chloride / Q000627:therapeutic use; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000209:etiology; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D000549:Ambenonium Chloride; D000324:Adrenocorticotropic Hormone; D011729:Pyridostigmine Bromide
Considerazioni su episodiche manifestazioni cliniche riferibili a probabile interessamento del sistema immunitario in due sorelle affette da miastenia gravis